ENDRA Life Sciences Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ENDRA Life Sciences Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • ENDRA Life Sciences Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.51M, a 51.8% increase year-over-year.
  • ENDRA Life Sciences Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$7.98M, a 35.5% increase year-over-year.
  • ENDRA Life Sciences Inc. annual Operating Income (Loss) for 2023 was -$10.5M, a 20% increase from 2022.
  • ENDRA Life Sciences Inc. annual Operating Income (Loss) for 2022 was -$13.2M, a 14.4% decline from 2021.
  • ENDRA Life Sciences Inc. annual Operating Income (Loss) for 2021 was -$11.5M, a 0.03% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$10.5M +$2.64M +20% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$13.2M -$1.66M -14.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$11.5M +$3.61K +0.03% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$11.5M -$658K -6.07% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$10.8M -$1.82M -20.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$9.02M -$4.39M -95% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$4.63M -$2.83M -158% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-11
2016 -$1.79M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.